The challenges of solid tumor for designer CAR-T therapies: a 25-year perspective
Sign Up to like & getrecommendations! Published in 2017 at "Cancer Gene Therapy"
DOI: 10.1038/cgt.2016.82
Abstract: Designer chimeric antigen receptor (CAR) T cells (dTc) have come to be the latest designer ‘drug’ for treatment of cancer. This technology has generated multiple apparent cures in the treatment of B-cell malignancies, but has… read more here.
Keywords: designer; designer car; solid tumor; tumor designer ... See more keywords